The Discounted Cash Flow (DCF) valuation of Pacira Biosciences Inc (PCRX) is 4.63 USD. With the latest stock price at 23.31 USD, the upside of Pacira Biosciences Inc based on DCF is -80.1%.
Based on the latest price of 23.31 USD and our DCF valuation, Pacira Biosciences Inc (PCRX) is a sell. selling PCRX stocks now will result in a potential gain of 80.1%.
| Range | Selected | |
| WACC / Discount Rate | 5.8% - 7.8% | 6.8% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 0.80 - 27.33 | 4.63 |
| Upside | -96.6% - 17.2% | -80.1% |